Advanced Biomed Inc (NASDAQ:ADVB) shares are trading lower during Wednesday's premarket session. The move follows a massive rally on Tuesday. Investors appear to be taking profits after the stock surged over 51% yesterday.

All-Stock Acquisition Details

The volatility follows an April 2, announcement. The Company entered a Share Purchase Agreement with Acellent Technologies. Advanced Biomed will acquire 100% of the equity interest.

The deal is an all-stock transaction. The Company will issue 270,000 shares of common stock to the seller.

The deal carries an estimated value of $1.08 million. This assumes a share price of $4.00.

Strategic Pivot Into AI

Acellent Technologies provides AI-powered financial verification and audit solutions. This marks a diversification for Advanced Biomed. The Company typically focuses on microfluidic biochip technologies and cancer diagnosis.

Existing products include the AC-1000 and A+CellScan. These devices aid in early cancer screening and treatment staging.

Technical Analysis

At $6.09, ADVB is trading 29.6% above its 20-day simple moving average (SMA), the stock’s average price over the last 20 sessions, which suggests the short-term trend has been strong and extended. It's also trading 0.3% below its 100-day SMA,

The relative strength index (RSI), a momentum gauge, is 72.11.

  • Key Resistance: $6.50
  • Key Support: $4.50

ADVB Stock Price Activity: Advanced Biomed shares were down 7.36% at $6.04 during premarket trading on Wednesday, according to Benzinga Pro data.

Photo Courtesy: KeyFame on Shutterstock.com